Canaccord Genuity Maintains a 'Buy' on St. Jude Medical (NYSE: STJ); Buy on Weakness

April 19, 2012 9:12 AM EDT
Get Alerts STJ Hot Sheet
Price: $80.82 --0%

Rating Summary:
    3 Buy, 21 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on St. Jude Medical (NYSE: STJ) price target of $50.00.

Analyst, Jason R. Mills, said, "We maintain our rating and would incrementally accumulate shares on weakness heading into the HRS meeting in Boston next month. Clearly investors are concerned more negative noise could come out at HRS on Riata/Durata. On the other hand, positive update from the Durata registry could begin the “healing process” for EPs as it relates to their views on STJ’s CRM portfolio, in which case a rally in the stock could ensue, as investors may then focus attention on future CRM share gain potential and the company’s robust new product pipeline."

For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.

Shares of St. Jude Medical closed at $38.39 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View